Skip to main content
. 2019 May 14;12:685–702. doi: 10.2147/DMSO.S201594

Table 1.

Characteristics of the study population

Parameter UW, median (lower; upper quartiles) NW, median (lower; upper quartiles) OW, median (lower; upper quartiles) OB, median (lower; upper quartiles) P-value
Body height (cm) 1.70 (1.64; 1.73) 1.67 (1.61; 1.73) 1.66 (1.60; 1.73) 1.70 (1.64; 1.77) E
Body weight (kg) 44.50 (41.70; 48.28) 55.80 (50.70; 61.01) 70.30 (65.05; 76.30) 91.10 (82.30; 102.65) A-F
Waist circumference (cm) 63.50 (60; 67.25) 69.00 (65.00; 73.00) 80 (75; 84) 93.5 (87.38; 100) A-F
Hip circumference (cm) 84 (82.75; 86.25) 91 (88; 94) 100 (97; 103) 110 (107; 115) A-F
BMI (kg m-2) 15.74 (15.36; 16.2) 20.22 (18.74; 21.56) 25.48 (24.58; 26.75) 31.37 (29.49; 33.85) A-F
BMI z-score −1.43 (−1.51; −1.33) −0.49 (−0.8; −0.21) 0.62 (0.43; 0.88) 1.85 (1.46; 2.37) A-F
Body weight z-score −1.2 (−1.38; −0.96) −0.48 (−0.8; −0.14) 0.46 (0.12; 0.84) 1.8 (1.23; 2.54) A-F
Waist circumference z-score −0.97 (−1.29; −0.63) −0.46 (−0.83; −0.1) 0.55 (0.09; 0.91) 1.79 (1.23; 2.39) A-F
Hip circumference z-score −1.23 (−1.37; −0.97) −0.44 (−0.78; −0.09) 0.59 (0.25; 0.93) 1.72 (1.38; 2.29) A-F
WHtR 0.38 (0.36; 0.39) 0.41 (0.39; 0.43) 0.48 (0.46; 0.5) 0.55 (0.52; 0.58) A-F
WHR 0.75 (0.71; 0.81) 0.76 (0.73; 0.78) 0.8 (0.77; 0.83) 0.85 (0.81; 0.89) B-F
BPS (mm Hg) 116.5 (109.75; 121.25) 115 (107; 123) 122 (113; 133) 131.5 (124; 144.25) B-F
BPD (mmHg) 70 (60.5; 78.25) 65 (60; 70) 67 (61; 73) 71.5 (65; 77.25) D, E
Pulse rate 85 (76.5; 96.25) 85 (75; 92) 85 (77; 92.5) 86 (76.75; 96) NS
TP (g/L) 78 (76.58; 83.05) 79.9 (77; 82.9) 79.9 (76.9; 82.75) 80 (77.2; 83.03) NS
Albumin, Alb (g/L) 50.65 (48.78; 53.65) 50.8 (48.9; 52.7) 50.3 (48.65; 52.3) 49.7 (47.7; 52.03) C, E
ALT (U/L) 9.5 (7.75; 11) 10 (8; 13) 13 (9; 19) 25 (14; 39.25) A-F
AST (U/L) 14 (13; 15.25) 15 (13; 17) 16 (13; 19) 19 (15; 25) C, E, F
ALP (U/L) 103.5 (70; 159.25) 93 (76; 121) 93 (75.5; 120.5) 101 (81.75; 126.75) NS
GGT (U/L) 15 (11.75; 16) 15 (12; 19) 18 (14; 26) 26 (19; 34.25) B-F
BChE (U/L) 7,351 (6661.25; 7891.75) 7,709 (7014.5; 8,478) 8,350 (7,610; 9217.5) 9294.5 (8,463; 10,127.5) B-F
PA1 (g/L) 0.24 (0.21; 0.27) 0.25 (0.22; 0.28) 0.25 (0.22; 0.29) 0.27 (0.23; 0.29) C,E
BilT (mmol/L) 16.8 (13.73; 22.9) 13.3 (9.8; 17.3) 12.8 (9.8; 16.25) 12.25 (9.3; 16.23) NS
CB (mmol/L) 6.3 (5.2; 8.25) 5.3 (3.8; 6.9) 4.8 (3.5; 6.6) 4.65 (3.5; 6.23) NS
UCB (mmol/L) 10.7 (7.93; 14.3) 8.1 (5.9; 10.55) 7.7 (6; 10) 7.55 (5.65; 10.1) NS
TBA (mmol/L) 2.8 (2; 4.38) 2.4 (1.4; 3.6) 2 (1.15; 3.2) 2 (1.3; 3.13) B, D
FPG (mmol/L) 4.3 (3.87; 4.55) 4.28 (4; 4.56) 4.28 (3.99; 4.58) 4.31 (4; 4.64) NS
TG (mmol/L) 0.67 (0.53; 0.88) 0.71 (0.53; 0.96) 0.81 (0.58; 1.07) 1.04 (0.75; 1.44) C, E, F
TC (mmol/L) 3.9 (3.43; 4.32) 3.84 (3.41; 4.3) 3.95 (3.46; 4.45) 4.25 (3.82; 4.7) C, E, F
HDL-C (mmol/L) 1.42 (1.12; 1.73) 1.34 (1.17; 1.54) 1.24 (1.1; 1.47) 1.13 (0.99; 1.26) B-E
LDL-C (mmol/L) 1.94 (1.69; 2.53) 2.05 (1.71; 2.43) 2.19 (1.81; 2.55) 2.54 (2.16; 2.85) B, C, E, F
ApoA1 (g/L) 1.39 (1.21; 1.49) 1.33 (1.22; 1.46) 1.26 (1.16; 1.4) 1.24 (1.13; 1.34) B-E
ApoB (g/L) 0.58 (0.49; 0.7) 0.6 (0.52; 0.7) 0.66 (0.56; 0.75) 0.76 (0.64; 0.86) B-F
MetS (n/N,%) 0/122 (0.0%) 2/732 (0.3%) 10/188 (5.3%) 59/194 (30.4%) B-F

Note: *P=Kruskal–Wallis multiple-comparison Z value test. P-values <0.05 were considered statistically significant: A=UW vs NW, B=UW vs OW, C=UW vs OB, D=NW vs OW, E=NW vs OB, F=OW vs OB.

Abbreviations: UW, underweight group; NW, normal weight group; OW, overweight group; OB, obese group; BMI, body mass index; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio; BPS, systolic blood pressure; BPD, diastolic blood pressure; TP, total protein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transpeptidase; PA1, pre-albumin; BilT, total bilirubin; CB, conjugated bilirubin; UCB, un-conjugated bilirubin; TBA, total bile acid; FPG, fasting plasma glucose; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; ApoA1, apolipoprotein A1; AopB, apolipoprotein B.